Human clinical research, including multiple randomized, double-blind, placebo-controlled trials, has investigated the effects of METABOLAID® supplementation in overweight adults, assessing body weight, body composition, appetite, and metabolic markers compared with placebo.
Findings suggest this polyphenol blend may support weight management and metabolic balance when combined with a healthy lifestyle (2), with additional evidence demonstrating effects on appetite-related hormones, including increases in GLP-1, alongside reduced appetite sensation and calorie intake in controlled settings.
Clinical studies report reductions in body fat mass of approximately 6.9% over 12 weeks (7), as well as ~3 kg weight loss (~3.4% body weight) and ~1.7% reduction in body fat over 90 days (8). Additional improvements include ~7% reductions in cholesterol, with further randomized, double-blind studies showing reductions in systolic and diastolic blood pressure (9).
Overall, evidence suggests METABOLAID® may support appetite regulation, body composition, and cardiometabolic health; however, findings are based on relatively small, short-term studies and require further validation.
In short: METABOLAID® for Metabolic Health
- Supports satiety and appetite regulation, including effects on GLP-1
- May help reduce calorie intake
- Clinically studied for reductions in body fat mass (up to 6.9%)
- Supports weight management, with ~3 kg weight loss reported
Helps maintain healthy cholesterol and blood pressure